annual interest expense:
$126.60M(NaN%)Summary
- As of today (May 29, 2025), NBIX annual interest expense is $126.60 million
- During the last 3 years, NBIX annual interest expense has risen by +$100.80 million (+390.70%).
- NBIX annual interest expense is now at all-time high.
Performance
NBIX Interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly interest expense:
N/ASummary
- NBIX quarterly interest expense is not available.
Performance
NBIX quarterly interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM interest expense:
N/ASummary
- NBIX TTM interest expense is not available.
Performance
NBIX TTM interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Interest expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
NBIX Interest expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +390.7% | - | - |
| 5 y5 years | +295.6% | - | - |
NBIX Interest expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +390.7% | ||||
| 5 y | 5-year | at high | +390.7% | ||||
| alltime | all time | at high | >+9999.0% |
NBIX Interest expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $126.60M(+390.7%) | - | - |
| Mar 2023 | - | $1.10M(-8.3%) | $4.50M(-64.3%) |
| Sep 2022 | - | $1.20M(-45.5%) | $12.60M(-30.0%) |
| Jun 2022 | - | $2.20M(-15.4%) | $18.00M(-18.2%) |
| Mar 2022 | - | $2.60M(-60.6%) | $22.00M(-14.7%) |
| Dec 2021 | $25.80M(-21.3%) | $6.60M(0.0%) | $25.80M(-4.4%) |
| Sep 2021 | - | $6.60M(+6.5%) | $27.00M(-6.6%) |
| Jun 2021 | - | $6.20M(-3.1%) | $28.90M(-6.8%) |
| Mar 2021 | - | $6.40M(-17.9%) | $31.00M(-5.5%) |
| Dec 2020 | $32.80M(+2.5%) | $7.80M(-8.2%) | $32.80M(-1.2%) |
| Sep 2020 | - | $8.50M(+2.4%) | $33.20M(+1.5%) |
| Jun 2020 | - | $8.30M(+1.2%) | $32.70M(+1.2%) |
| Mar 2020 | - | $8.20M(0.0%) | $32.30M(+0.9%) |
| Dec 2019 | $32.00M | $8.20M(+2.5%) | $32.00M(+1.5%) |
| Sep 2019 | - | $8.00M(+1.3%) | $31.53M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $7.90M(0.0%) | $31.20M(+1.0%) |
| Mar 2019 | - | $7.90M(+2.2%) | $30.90M(+1.3%) |
| Dec 2018 | $30.50M(+56.2%) | $7.73M(+0.8%) | $30.50M(+1.0%) |
| Sep 2018 | - | $7.67M(+1.1%) | $30.19M(+1.1%) |
| Jun 2018 | - | $7.59M(+1.2%) | $29.85M(+10.4%) |
| Mar 2018 | - | $7.50M(+1.1%) | $27.03M(+38.4%) |
| Dec 2017 | $19.52M(>+9900.0%) | $7.42M(+1.1%) | $19.52M(+61.3%) |
| Sep 2017 | - | $7.34M(+53.9%) | $12.10M(+153.9%) |
| Jun 2017 | - | $4.77M(>+9900.0%) | $4.77M(>+9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00 | $0.00 |
| Dec 2015 | $0.00(-100.0%) | - | - |
| Dec 2008 | $7.03M | - | - |
FAQ
- What is Neurocrine Biosciences annual interest expense?
- What is the all time high annual interest expense for Neurocrine Biosciences?
- What is the all time high quarterly interest expense for Neurocrine Biosciences?
- What is the all time high TTM interest expense for Neurocrine Biosciences?
What is Neurocrine Biosciences annual interest expense?
The current annual interest expense of NBIX is $126.60M
What is the all time high annual interest expense for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual interest expense is $126.60M
What is the all time high quarterly interest expense for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly interest expense is $8.50M
What is the all time high TTM interest expense for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM interest expense is $33.20M